Critical Analysis: NovelStem International (NSTM) and The Competition

NovelStem International (OTCMKTS:NSTMGet Free Report) is one of 26 publicly-traded companies in the “Retail stores, not elsewhere classified” industry, but how does it compare to its peers? We will compare NovelStem International to related companies based on the strength of its risk, profitability, earnings, analyst recommendations, institutional ownership, dividends and valuation.

Risk & Volatility

NovelStem International has a beta of 0.42, indicating that its stock price is 58% less volatile than the S&P 500. Comparatively, NovelStem International’s peers have a beta of 0.82, indicating that their average stock price is 18% less volatile than the S&P 500.

Profitability

This table compares NovelStem International and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
NovelStem International -9,166.67% N/A -73.18%
NovelStem International Competitors -25.06% -60.82% -0.94%

Earnings & Valuation

This table compares NovelStem International and its peers revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
NovelStem International $10,000.00 -$4.19 million -0.30
NovelStem International Competitors $49.55 billion $125.40 million 6.40

NovelStem International’s peers have higher revenue and earnings than NovelStem International. NovelStem International is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Insider and Institutional Ownership

29.3% of shares of all “Retail stores, not elsewhere classified” companies are owned by institutional investors. 13.6% of NovelStem International shares are owned by insiders. Comparatively, 16.9% of shares of all “Retail stores, not elsewhere classified” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for NovelStem International and its peers, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NovelStem International 0 0 0 0 N/A
NovelStem International Competitors 88 811 1393 56 2.60

As a group, “Retail stores, not elsewhere classified” companies have a potential upside of 12.67%. Given NovelStem International’s peers higher possible upside, analysts clearly believe NovelStem International has less favorable growth aspects than its peers.

Summary

NovelStem International peers beat NovelStem International on 9 of the 10 factors compared.

About NovelStem International

(Get Free Report)

NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida.

Receive News & Ratings for NovelStem International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovelStem International and related companies with MarketBeat.com's FREE daily email newsletter.